Oana Ciofu

16.8k total citations · 6 hit papers
122 papers, 12.8k citations indexed

About

Oana Ciofu is a scholar working on Molecular Biology, Molecular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Oana Ciofu has authored 122 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Molecular Biology, 71 papers in Molecular Medicine and 65 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Oana Ciofu's work include Bacterial biofilms and quorum sensing (91 papers), Antibiotic Resistance in Bacteria (71 papers) and Cystic Fibrosis Research Advances (57 papers). Oana Ciofu is often cited by papers focused on Bacterial biofilms and quorum sensing (91 papers), Antibiotic Resistance in Bacteria (71 papers) and Cystic Fibrosis Research Advances (57 papers). Oana Ciofu collaborates with scholars based in Denmark, United States and Spain. Oana Ciofu's co-authors include Niels Høiby, Thomas Bjarnsholt, Søren Molin, Michael Givskov, Peter Østrup Jensen, Tim Tolker‐Nielsen, Claus Moser, Helle Krogh Johansen, Zhijun Song and Niels H�iby and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and PLoS ONE.

In The Last Decade

Oana Ciofu

121 papers receiving 12.6k citations

Hit Papers

Antibiotic resistance of bacterial biofilms 2010 2026 2015 2020 2010 2022 2011 2012 2010 500 1000 1.5k 2.0k

Peers

Oana Ciofu
Pradeep K. Singh United States
Daniel J. Wozniak United States
Claus Moser Denmark
Gerald B. Pier United States
Liang Yang Singapore
Oana Ciofu
Citations per year, relative to Oana Ciofu Oana Ciofu (= 1×) peers Peter Østrup Jensen

Countries citing papers authored by Oana Ciofu

Since Specialization
Citations

This map shows the geographic impact of Oana Ciofu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oana Ciofu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oana Ciofu more than expected).

Fields of papers citing papers by Oana Ciofu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oana Ciofu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oana Ciofu. The network helps show where Oana Ciofu may publish in the future.

Co-authorship network of co-authors of Oana Ciofu

This figure shows the co-authorship network connecting the top 25 collaborators of Oana Ciofu. A scholar is included among the top collaborators of Oana Ciofu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oana Ciofu. Oana Ciofu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akay, Şeref, et al.. (2025). Liquid crystalline coatings loaded with colistin for preventing development of biofilms on orthopedic implants. Journal of Colloid and Interface Science. 687. 630–642. 1 indexed citations
2.
Lerche, Christian Johann, et al.. (2024). Bacteriophage therapy and infective endocarditis – is it realistic?. Apmis. 132(10). 675–687. 1 indexed citations
3.
Ahmad, Nasir M., et al.. (2024). Antibacterial and anti-biofilm activities of antibiotic-free phosphatidylglycerol/docosahexaenoic acid lamellar and non-lamellar liquid crystalline nanoparticles. Journal of Colloid and Interface Science. 669. 537–551. 7 indexed citations
4.
Høiby, Niels, Claus Moser, & Oana Ciofu. (2024). The microenvironment in antibiotic susceptibility testing. Apmis. 132(12). 985–991. 1 indexed citations
5.
Høiby, Niels, et al.. (2024). Increased susceptibility to azithromycin of Pseudomonas aeruginosa biofilms using RPMI 1640 testing media. Apmis. 132(12). 1086–1095. 2 indexed citations
6.
Armengol, Eva Sanchez, Kasper Nørskov Kragh, Tim Tolker‐Nielsen, et al.. (2023). Colistin Enhances Rifampicin’s Antimicrobial Action in Colistin-Resistant Pseudomonas aeruginosa Biofilms. Antimicrobial Agents and Chemotherapy. 67(4). e0164122–e0164122. 9 indexed citations
7.
Ciofu, Oana, Claus Moser, Peter Østrup Jensen, & Niels Høiby. (2022). Tolerance and resistance of microbial biofilms. Nature Reviews Microbiology. 20(10). 621–635. 667 indexed citations breakdown →
8.
Ciofu, Oana, Sherie Smith, & Jens Lykkesfeldt. (2019). A systematic Cochrane Review of antioxidant supplementation lung disease for cystic fibrosis. Paediatric Respiratory Reviews. 33. 28–29. 4 indexed citations
9.
Skov, Marianne, Tacjana Pressler, Jens Lykkesfeldt, et al.. (2014). The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection — A pilot study. Journal of Cystic Fibrosis. 14(2). 211–218. 28 indexed citations
10.
Ciofu, Oana, Helle Krogh Johansen, Kasper Aanæs, et al.. (2013). P. aeruginosa in the paranasal sinuses and transplanted lungs have similar adaptive mutations as isolates from chronically infected CF lungs. Journal of Cystic Fibrosis. 12(6). 729–736. 53 indexed citations
11.
Bjarnsholt, Thomas, Oana Ciofu, Søren Molin, Michael Givskov, & Niels Høiby. (2013). Applying insights from biofilm biology to drug development — can a new approach be developed?. Nature Reviews Drug Discovery. 12(10). 791–808. 413 indexed citations
12.
Yang, Lei, Lars Jelsbak, Rasmus L. Marvig, et al.. (2011). Evolutionary dynamics of bacteria in a human host environment. Proceedings of the National Academy of Sciences. 108(18). 7481–7486. 267 indexed citations
13.
Jensen, Peter Østrup, Jens Lykkesfeldt, Thomas Bjarnsholt, et al.. (2011). Poor Antioxidant Status Exacerbates Oxidative Stress and Inflammatory Response to Pseudomonas aeruginosa Lung Infection in Guinea Pigs. Basic & Clinical Pharmacology & Toxicology. 110(4). 353–358. 13 indexed citations
14.
Schjerling, Charlotte Karlskov, Nikolai Kirkby, Nadine Hoffmann, et al.. (2011). Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients. Apmis. 119(4-5). 263–274. 48 indexed citations
15.
Hoffmann, Nadine, Thomas Bovbjerg Rasmussen, Peter Østrup Jensen, et al.. (2005). Novel Mouse Model of Chronic Pseudomonas aeruginosa Lung Infection Mimicking Cystic Fibrosis. Infection and Immunity. 73(4). 2504–2514. 142 indexed citations
16.
Bagge, Niels, Martín Schuster, Morten Hentzer, et al.. (2004). Pseudomonas aeruginosa Biofilms Exposed to Imipenem Exhibit Changes in Global Gene Expression and β-Lactamase and Alginate Production. Antimicrobial Agents and Chemotherapy. 48(4). 1175–1187. 256 indexed citations
17.
Bagge, Niels, Morten Hentzer, Jens Bo Andersen, et al.. (2004). Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa Biofilms. Antimicrobial Agents and Chemotherapy. 48(4). 1168–1174. 135 indexed citations
18.
Fluge, G, et al.. (2001). Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clinical Microbiology and Infection. 7(5). 238–243. 38 indexed citations
19.
Bagge, Niels, Oana Ciofu, Lene Theil Skovgaard, & Niels Høiby. (2000). Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm‐growing Pseudomonas aeruginosa due to chromosomal β‐lactamase. Apmis. 108(9). 589–600. 42 indexed citations
20.
Høiby, Niels, et al.. (1996). Use of carbapenems and other antibiotics for pulmonary infections in patients with cystic fibrosis. The Pediatric Infectious Disease Journal. 15(8). 738–743. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026